Orient Pharma Co Ltd Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ORIENT PHARMA CO LTD, and what generic and branded alternatives to ORIENT PHARMA CO LTD drugs are available?
ORIENT PHARMA CO LTD has four approved drugs.
Drugs and US Patents for Orient Pharma Co Ltd
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Orient Pharma Co Ltd | PITAVASTATIN CALCIUM | pitavastatin calcium | TABLET;ORAL | 205932-003 | Feb 3, 2017 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Orient Pharma Co Ltd | GLYBURIDE | glyburide | TABLET;ORAL | 206483-003 | Feb 22, 2019 | AB1 | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Orient Pharma Co Ltd | PITAVASTATIN CALCIUM | pitavastatin calcium | TABLET;ORAL | 205932-002 | Feb 3, 2017 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Orient Pharma Co Ltd | VANCOMYCIN HYDROCHLORIDE | vancomycin hydrochloride | CAPSULE;ORAL | 210729-002 | Apr 29, 2019 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.